| |
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910780301103321 |
|
|
Autore |
Staff Institute of Medicine |
|
|
Titolo |
Assessment of the CDC Anthrax vaccine safety and efficacy research program [[electronic resource]] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, : National Academies Press, 2002 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (179 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Anthrax -- Vaccination |
Public health |
Anthrax - Vaccination - Research - United States |
Bacterial Vaccines |
Evaluation Studies as Topic |
Health Care Evaluation Mechanisms |
Quality of Health Care |
Bacillaceae Infections |
Investigative Techniques |
Vaccines |
Health Services Administration |
Gram-Positive Bacterial Infections |
Bacterial Infections |
Health Care Quality, Access, and Evaluation |
Health Care |
Biological Products |
Complex Mixtures |
Bacterial Infections and Mycoses |
Diseases |
Program Evaluation |
Drug Evaluation |
Anthrax |
Anthrax Vaccines |
Public Health |
Health & Biological Sciences |
Communicable Diseases |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
""Front Matter""; ""Preface""; ""Reviewers""; ""Contents""; ""Figures, Tables, and Boxes""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Background""; ""3 The CDC Anthrax Vaccine Research Plan""; ""4 Proposed Studies on the Efficacy of the Anthrax Vaccine""; ""5 Proposed Studies on the Safety of the Anthrax Vaccine""; ""6 Proposed Studies on the Acceptability of the Anthrax Vaccine""; ""7 Summary Assessment of the CDC Anthrax Vaccine Research Plan""; ""Appendix A Biographical Sketches""; ""Appendix B Information-Gathering Meeting Agendas"" |
""Appendix C Anthrax Vaccine Safety & Efficacy Research Plan""""Appendix D Food and Drug Administration Final Rule: New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible""; ""Appendix E Department of Defense Memorandum: Reintroduction of the Anthrax Vaccine Immunization Program""; ""Appendix F Institute of Medicine: CDC Anthrax Vaccine Safety & Efficacy Research Program. Interim Report Findings and Recommendations1"" |
""Appendix G Institute of Medicine: The Anthrax Vaccine: Is It Safe? Does It Work? Findings and Recommendations1"" |
|
|
|
|
|
|
|
| |